Contract awardedRadioisotopes

PRRT (Peptide Receptor Radionuclide Therapy)

Provision of Peptide Receptor Radionuclide Therapy (PRRT) pharmaceutical supplies for clinical use. This contract involves the direct procurement of specialised radiopharmaceutical treatments for patient care within a hospital setting.

Awarded value
£1.8m
As published
Published
10 November 2025
Contract length
13 months
Ends 31 December 2026

What the contract covers

Supply of specialist pharmaceutical products for Peptide Receptor Radionuclide Therapy to support clinical oncology and nuclear medicine treatment programmes.

  • PRRT (Peptide Receptor Radionuclide Therapy)

Terms and requirements

Procedure
Direct award
Initial term
13 months
Contract dates
24 November 2025 to 31 December 2026
Certifications asked for
None stated
Lots
1
Suitable for SMEs
Not stated
CPV codes
33000000

Services in this contract

Lifecycle

  1. Published
  2. Contract awardedto Novartis Pharmaceuticals UK Limited
  3. Contract starts
  4. Contract ends
The buyer

Belfast Health and Social Care Trust

Type
Locked
Contracts, 24 months
Locked
Recorded value
Locked
Typical contract
Locked
Radioisotopes contracts, 24 months
Locked
Buys mostLocked
Contact details
Email
Locked
Address
Locked
See everything Belfast Health and Social Care Trust buys
The supplier

Novartis Pharmaceuticals UK Limited

Contracts won, 24 months
Locked
Value won, 24 months
Locked
Buyers, 24 months
Locked
Size
Locked
Companies House number
Locked
Main buyersLocked
Contact details
Email
Locked
Website
Locked
See everything Novartis Pharmaceuticals UK Limited has won

Similar radioisotopes contracts and prices

41 radioisotopes contracts were awarded in the last 24 months. See who won them and what they went for, next to this one.

See who won them →

Cite this contract

Link
https://bidskim.com/tender/333707/prrt-peptide-receptor-radionuclide-therapy
Buyer reference
DAC20289
Open contracting ID
ocds-h6vhtk-05dd8b
Last checked
5 November 2026

Belfast Health and Social Care Trust. PRRT (Peptide Receptor Radionuclide Therapy). Contract award, 10 November 2025. BidSkim, https://bidskim.com/tender/333707/prrt-peptide-receptor-radionuclide-therapy (accessed 5 November 2026).